Alpha-I antitrypsin (z lA'T) is a major plasma protein, being the predominant component of the ad-globulin band seen on classical serum electrophoresis. Deficiency of the protein was associated with early-onset emphysema by Laurell and Eriksson I in 1963, and in 1968 an association between deficiency and liver disease was noted.' Although early studies of z l A'T function concentrated on the ability of the protein to inhibit trypsin activity (hence the original name), careful analysis of substrate specificity revealed that this was something of a misnomer. The protein can inhibit a wide variety of proteinases, but the preferred substrate is leucocyte elastase derived from neutrophils.' In this review the protein will be referred to as edA'T, but the finding that trypsin is not the major substrate has led to the use of alternative names such as ':Xl protease inhibitor' by many authors.
The :xIAT protein is readily accessible, and is a major proteinase inhibitor, and its gene is frequently affected by mutations. As a consequence, it has been the subject of intensive studies by protein chemists, geneticists and clinicians." 7 The present review is written primarily for the clinical chemist. Its purpose is to summarize current understanding of the molecular basis of action of z IAT and the clinical consequences of IX IAT deficiency. The range of techniques available at present for the laboratory investigation of :x IAT deficiency is outlined and the circumstances in which they should be used are defined.
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STRUCTURE AND FUNCTION OF THE C!lAT PROTEIN AND ITS GENE
Human IX IAT consists of a single chain of 394 amino acids, but the addition of three complex carbohydrate side chains increases the molecular weight to about 52 kDa for the mature protein.
The reactive site of IX IAT (located around methionine at position 358) provides a 'pseudosubstrate' for proteinases, with the result that a tight complex is formed between the proteinase and :x IAT. This complex formation is essentially irreversible, so thatz l A'T functions as a suicide molecule. If the proteinase cleaves acIAT, the complex may dissociate to liberate the short Cterminal fragment while the N-terminal fragment remains bound to the enzyme. A clearer picture of how ad AT functions has been made available by analysis of its three dimensional structure. The crystal structure of Q( IAT was determined using IX IAT which had been cleaved by chymotrypsin," and showed a globular molecule consisting of a predominant f1 sheet, together with two lesser fJ sheets and eight Q( helices located mainly underneath the first fJ sheet. The most striking feature of this structure was that, after cleavage by chymotrypsin, the two amino acids which had been linked by the bond which was cleaved by the enzyme (residues 358 and 359) were a considerable distance apart. Loebermann et al. H predicted that cleavage had allowed a large section of what had been a stressed external loop to fall back to form an extra strand in the A sheet, so increasing the stability of the structure. The structure of intact IXIAT has not yet been determined, but it is likely that the reactive centre is exposed (essentially as predicted by Loebermann et al. H ) 111 such a way as to provide temptation for proteinases.
IX IAT is a member of the serpin (serine proteinase inhibitor) family of proteins which share high sequence hornology.v'" Proteinases themselves have a wide variety of critical FIGLJRE I. Structure of the gene coding for a l AT. Shaded boxes represent exons (I to V), and introns are represented by a solid line. The sites of the Sand Z mutations are shown, together with Bst Ell restriction site and the active site ( Met'"}, functions, such as processing of precursor proteins, digestion, degradation and defence. Given the potential for damage which these enzymes have, it is not surprising that the role of anti-proteinases is equally important (as exemplified by diseases associated with « IAT deficiency). In addition to other proteinase inhibitors such as :x l-antichymotrypsin and antithrombin, the serpin family also includes non-proteinases such as angiotensinogen, thyroxine binding globulin, cortisol binding globulin and ovalbumin.
The gene for :xIAT (the Pi, or proteinase inhibitor, locus) has the chromosomal location 14q32·1. 11 The gene, which consists of seven exons and is [2·2 kb in length," is one of a cluster of serpin genes located in this region. In humans, the protein is synthesized primarily in liver, and to a lesser extent in monocytes. Different promoter regions are used by hepatocytes and rnonocytes, and mRNA species constituted from differing numbers of exons are found in these tissues. In liver, exons IC to V are transcribed, while in monocytes mRNA species which include exons IA and IB are also found. Initiation of protein synthesis occurs at the start of exon II, however, so that the protein produced in both tissues is likely to be identical.
Regulation of :xIAT gene expression has been studied extensively. As rzlAT is an acute phase protein, its hepatic expression can vary according to circumstances. The principal modulator of hepatic :x IAT gene expression is probably interleukin 6 (IL6), but in macrophages neutrophil elastase itself may regulate :x IAT synthesis. n Several regulatory regions have been identified in the promoter region of the :x IAT gene.?
Like other secretory proteins, :x IAT enters the exocytic pathway by translocation across the membrane of the rough endoplasmic reticulum Over 90 genetically determined variants of rzlAT have been identified, 14 most of which are associated with normal amounts and activity of the protein (see Table I for some examples). Nomenclature of atIAT and its variants is somewhat confusing. Initially, variants were named according to their mobility on starch gel electrophoresis (F= fast, S = slow and M = medium). According to the proteinase inhibitor (Pi) system of nomenclature, 15.16 atIAT variants are now described by a letter of the alphabet which is related to relative mobility on isoelectric focusing gels. The predominant normal variant found in all populations, designated M, can be further subdivided into at least eight subtypes (MI, M2, M3, etc.) which differ by one or two amino acids. Several mutations associated with varying degrees of :x IAT deficiency have been identified, the most common being the Z and S variants (Table I) . Rare variants are identified by place names locating the birthplace of the oldest individual tested in a pedigree (e.g. Mpittsburgh)' Mutations which result in absence of immunoreactive protein (e.g. insertions and deletions causing a frame-shift mutation) are described as null. The alleles coding for these null variants were originally represented in genotypes by a dash (e.g. Pi M-), but are now designated as Pi*QO.
The Z mutation, which is the most common cause of disease associated with alAT abnormality, results from a single base substitution in exon V. This mutation converts glutamic acid to lysine at position 342,n and as a consequence hepatocytes of ZZ homozygotes secrete only 10% to 15% the normal quantity of atiAT. The abnormal protein accumulates in the endoplasmic reticulum of hepatocytes, forming aggregates which are visible on microscopy. Lomas conditions and at high temperatures, normal o l A'T can dimerize as the reactive loop of one molecule is inserted into a gap in the A sheet of another. The Z mutation, which occurs at the base of the reactive centre loop, allows this dimerization and subsequent polymerization to occur spontaneously at 37°C. In addition to defective secretion from the liver, the Z protein also appears to be compromised in its ability to bind elastase,'? so that o l A'T deficiency in the homozygous ZZ individual results from a combination of quantitative and qualitative defects. Another less common mutation causing IXIAT deficiency, Siiyama, is also associated with accumulation of IXIAT in hepatocytes." The S mutation converts glutamic acid at position 264 to valine.?" The S variant is synthesized in normal quantities, but the variant appears to be partially degraded so that lower than normal amounts of protein are secreted. Some other less common alleles associated with IXIAT deficiency also appear to result from increased degradation of the newly formed protein. Both Mheerlcn and Mprocida are the result of single base substitutions which alter a single amino acid, and it is likely that the change causes instability of the molecule and consequent intracellular degradation.
One rare IXIAT variant, Pipill,hurgh, is associated with altered function. This variant is a result of a methionine at the active site being replaced by arginine, which converts the protein from an inhibitor of elastase to an inhibitor of thrombin, and hence causes a severe bleeding Ann cu« Biochem 1997: 34 disorder." More recently, the same amino acid change has been identified in a patient with a milder bleeding tendency. 22 The prevalence of the various gene types in any locality is best obtained from the 'gene frequency' which can be defined as the frequency of all genes of a particular type in the given population, whether occurring in heterozygotes or homozygotes. Thus, Pi type MZ individuals contribute one Z gene to the total whereas type ZZ individuals contribute two.
In Europe, the gene frequency for type Z is highest on the North-Western seaboard of the continent. In the UK, the frequency of the Z allele is about 0·02. The mutation seems likely to have originated in Scandinavia, probably around 2000 years ag0 23 and to have been spread to the remainder of North-Western Europe by Viking colonization in the 9th to II th centuries AD. As with type S, the gene frequency is lower in the Eastern regions of the continent and both phenotypes are rare among non-Europeans. The increase in the population frequency of type Z implies that there may have been some advantage to the heterozygous state, though the nature of this is not known; suggestions include enhanced fertility or increased resistance to tuberculosis.
The geographical distribution of gene frequency Pi type S differs markedly from that of type Z. The value is greatest in the Iberian Peninsula, suggesting that the S mutation may have arisen in the North of that region in prehistoric times and spread eastwards by large-scale population movements. In the UK, the frequency of the S allele is about 0·04.
DEFICIENCY OF IXIAT AND LUNG DISEASE
Of the commoner abnormal phenotypes, homozygotes of type Z have been most frequently associated with emphysema. Their clinical, physiological and radiological features were originally described by Eriksson/" and these observations have been confirmed on many occasions. 25.26 Clinical aspects (PiZZ) Increasingly severe exertional dyspnoea is the most important symptom; this may occur as early as 30 years of age or may be delayed until the age of 70 or more. Cigarette smoking is strongly associated with early deterioration. The physiological features are similar to those of emphysematous patients of normal phenotype and include expiratory airflow limitation (attributable to loss of pulmonary elastic recoil), reduction in carbon dioxide transfer factor and increase in residual volume. The arterial blood gases usually deteriorate only in the later stages of the disease.
Deterioration in lung function probably begins in early adult life. A series of 22 adolescents homozygous for type Z aged 14 to 18 had normal lung function though their attitudes to smoking were similar to those of a control group.F This suggests that early diagnosis (perhaps by population screening methods) and an educational programme may be needed for children with this phenotype. In type Z homozygotes, cigarette smoking has a severe effect upon lung function and upon prognosis.e ' 26 In Swedish subjects of this phenotype, the cumulative probability of survival was shown to be much lower than in the normal population, smokers being at particular risk.2~Considerable deterioration has usually occurred before symptoms force the patient to seek medical advice. On the chest radiograph, the most striking feature is the predominant destruction of the lower zones of the lungs in contrast to the upper zone or more uniformly distributed disease commonly seen in emphysema of normal phenotype.t'-" The lower zones are thought to be more severely affected because of the greater blood flow per unit volume in that region; this is consistent with the prevailing view that the pulmonary damage is brought
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about by elastase released from circulating neutrophils. In pathological terms, IX IAT deficiency is associated with the panlobular form of emphysema.P'-v
The null phenotype A phenotype in which no IXIAT is produced at all (the 'null' phenotype) was first described by Talamo et a/. 3 l Homozygotes for null (Pi*QO) alleles may develop emphysema even in childhood.
Other Pi phenotypes and lung disease Most patients with emphysema are current or ex-smokers of the normal MM phenotype, but whether individuals of phenotypes other than ZZ also have a predisposition to develop emphysema is a matter of some controversy. Heterozygotes of type SZ have a serum IX IAT concentration about one-third the normal value and might thus appear to be at risk. Hutchison et a/.,32 however showed that all the SZ individuals with emphysema had a history of smoking and this phenotype in itself appears to carry little or no extra risk of emphysema. Heterozygotes of types MZ and MS are much commoner than those of type SZ and since they form 3% and 8%, respectively, of the UK population, the assessment of risk is important. There has been some controversy in the extensive literature on this subject but the most reasonable conclusion still seems to be that reached by Mittman." type MZ does not in itself appear to be an important risk factor, though a minority of MZ smokers can develop lung function abnormalities. Subjects of type MS appear to have no special risk of developing emphysema.
Pathogenesis of lung disease
In the experimental animal model, it is well established that emphysema can be produced by any enzyme which has elastolytic properties," and it is now generally believed that emphysema in individuals deficient in IXIAT is due to unopposed action of elastase. It is clear, however, that environmental and genetic factors other than IX IAT deficiency are involved ( Table  2 ). The true prognosis for type Z homozygotes is not known, since most cases present with respiratory disease and those with no symptoms seldom undergo detailed investigation. Larssorr" obtained data on 246 PiZ homozygotes in Sweden, but pointed out that in the Swedish population over 20 years of age there must be (3) interferes with the synthesis of elastin some 4000 individuals of this phenotype. In the UK likewise, from the estimated population frequency one would expect to find about 2000 PiZ homozygotes between the ages of 45 and 55, but only about 100 were observed in a national study lasting several years. 26 The whereabouts of the remaining 90% is unknown; a certain number will have succumbed to pulmonary or hepatic disease without being identified as Pi type Z homozygotes but it seems quite possible that many type Z homozygotes do not develop noticeable respiratory abnormalities and remain undetected. Though additional genetic factors are likely to be important, environmental factors cannot be doubted. Pulmonary damage due to ad AT deficiency can be further enhanced by exposure to cigarette smoke." In the human smoker, the wide range of susceptibility to the effects of tobacco smoke has not yet been satisfactorily explained, but smoke could adversely affect lung function in a number of ways. In smokers, the macrophages are increased in size and number and many more neutrophils are likely to be present. Cigarette smoke (and nicotine itself) can stimulate macrophages to secrete neutrophil chemoattractants. Thus, an increased burden of elastase within the lungs and airways will result. Cigarette smoke has been shown, in a number of studies, to inactivate :xIAT in vitro, but it seems doubtful whether a A distinctive pathological feature is the presence of diastase-resistant, PAS-positive, magenta-coloured globules 2-20 nm in diameter seen mainly in the periportal hepatocytes. This material is immunologically identical to od AT and can be seen in all homozygotes of Pi type Z and to a lesser extent in heterozygous carriers of the Z gene.
Jaundice lasts on average 3 months but occasionally will last for over 12 months. Low birth weight for gestational age, failure to thrive, hepatosplenomegaly, lethargy and increased susceptibility to septicaemia are common features. Of those with jaundice 5% die in infancy with decompensated cirrhosis. In the remainder jaundice clears and features of hepatitis remit, though 50% have persistently abnormal liver function tests with ongoing hepatic inflammation leading to cirrhosis, which in half becomes decompensated in the first or second decade with a recurrence of jaundice, hypoalbuminaemia, hyponatraemia and failure to thrive. Haematuria and albuminuria due to a glomerulopathy frequently appear at this time and may predispose to severe systemic hypertension and renal failure after liver transplantation. Death occurs within 4 years of decompensation unless liver transplantation is performed. In 25% of these children biochemical tests for liver disease become normal between 2 and 9 years of age and they appear to have a good prognosis, while in 25% there are no features of cirrhosis but there are continuing features of hepatic inflammation and the prognosis remains uncertain.
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Another 2% of PiZZ individuals, having had no features of liver disease in infancy, present in later childhood with complications of cirrhosis such as ascites, haemorrhage from portal hypertension or hepatomegalay. In adult life the reported risk of cirrhosis has ranged from 15 to 47%, with hepatoma in 15 to 29%. 38 Hepatoma can occur in the absence of cirrhosis" and men over the age of 50 are at particular risk. Liver and lung disease are probably present together in most adult type Z homozygotes. About 50% of a series of such subjects who underwent autopsy had cirrhosis and the majority of them had emphysema of various degrees of severi ty.39
Liver disease with other Pi phenotypes Although liver disease has been reported in both infants and adults with phenotype SZ, SS and FZ4(}-42 and an increased prevalence of MZ has been found in adult patients with cirrhosis and chronic active hepatitis, these may be chance observations." In Sveger's study," 13 of 54 asymptomatic PiSZ infants had high alanine aminotransferase values at 6 months of age as did one at 4 to 12 years. A confounding factor is that the PiZZ phenotype may give a SZ-like appearance on electrophoretic separation in the presence of liver disease. In our experience of almost 2000 infants and children with chronic liver disease PiZZ is the only phenotype more commonly represented than in the healthy population. PiMmalton and PiMdoarle, respectively 100 and 200 times rare than PiZ, produce low concentrations of serum rx IAT due to a defect in secretion from the liver. Too few have been reported to assess the risk of liver disease, though liver disease has been reported in an adult with PiMmalton.44
The pathogenesis of liver damage and progressive liver disease The relative contribution of different factors to liver damage and progressive liver disease in rx IAT deficiency remains unknown ( Table 2 ). The similarity in severity of liver disease in up to 80% of siblings who are homozygous for the Z mutation suggests that a second genetic factor may contribute to liver disease." Amongst possible genetically influenced mechanisms which may be implicated in pathogenesis are defects in chemotaxis," liver-specific autoimmune reactions" and HLA genes (class II DR3B gene was associated with liver disease while DR4 was apparently protectivej." The associations were weak, however, and other factors must be implicated. Evidence that liver disease correlates with a lag in intracellular degradation of IXIAT has been obtained recently by Wu et al. 48 We have observed two identical twins in whom the liver disease ran a disparate course, but the environmental factors which contribute are a matter for speculation." Increased aggregation of Z IXIAT protein during fever has been suggested as a mechanism of liver damage."
Two hypotheses are currently being considered in pathogenesis. The first proposes that accumulation of IXIAT in the hepatocyte causes the process(es) that lead to severe liver damage. Against this being the sole mechanism is the observation that only 70% of PiZZ infants have abnormal liver function tests and, in the course of a lifetime, at most 20 to 40% develop clinically significant liver disease despite accumulation occurring in all biopsied PiZZ subjects. Furthermore, accumulations are least conspicuous early in infancy when disease activity appears to be greatest.
The evidence stated in favour of the accumulation hypothesis is that while liver disease occurs in the other rare phenotypes with low serum levels and accumulation of IXIAT (e.g. PiMmalton) no liver disease occurs in PiQO homozygotes who have no PAS positive globules in the liver. In fact, studies of the liver histology in the exceedingly rare and genetically pleomorphic PiQO or in PiMmalton are limited to only one or two casesv" so that liver damage could occur as frequently as it occurs in PiZZ subjects. The evidence from the effect of the transfer of the Z gene to transgenic mice is inconclusive. Glycoprotein accumulation and infiltration with inflammatory cells occurs, but there is no increase in hepatic fibrosis.V
The second hypothesis, that a proteinaseanti proteinase imbalance is responsible (generally considered the cause of emphysema), has also been extended to the liver damage although it is difficult to obtain direct evidence of what may be happening in the hepatic microenvironment. With I g of elastase and I g of collagenase being produced daily, uninhibited action of such enzymes could cause disastrous tissue destruction and inflammation. Polymorphonuclear leucocytes stimulated by opsonized zymosan release proteinase which directly damage liver cells in vitro but cytotoxicity is decreased 75% by IXIAT.53 Both polymorphonuclear leucocytes and monocytes from PizZ subjects show enhanced activation, Ann Clin Biochem 1997: 34 mediated via membrane-bound serine esterases, compared to those from PiMM subjects. Proteinases could also damage extracellular matrix components. These are now known to be much more than structural macromolecules. They interact with parenchymal cells through specific receptors and thus influence cell function. They also interact with inflammatory cells." The increased degree of complement activation (C3dj C3 ratio) found in children with liver disease, particularly if severe, may be associated with diminished proteinase inhibition. It has yet to be shown that complement activation causes liver damage in this disorder.
The evidence quoted against this hypothesis is the absence of liver disease in the PiQO variant (see above). In favour is the observation that 23% of PiSZ infants have increased serum transaminases. These subjects do not have significant hepatic accumulation but do have low serum levels of IXIAT. By 12 years of age only 2% had elevated transaminase levels. This time course of return to normal of serum transaminase mirrors that seen in the PiZZ subject" and emphasizes the susceptibility of the newborn to liver dysfunction.
Any hypothesis should account for the fact that most liver disease starts in the first weeks of life. Many aspects of liver function and structure are relatively immature or inefficient in the first months of life which may account for the high frequency of liver disease presenting at this time. The hepatic extracellular matrix may be particularly susceptible in early infancy when many metabolites of matrix components are present in high concentration in serum. Udall'? suggested that the developmental leakiness of the newborn gut could allow foreign proteins into the portal circulation. When trapped in the liver they might stimulate proteinase release and induce hepatitis which could become progressive if there were insufficient proteinase inhibitors present to inactivate the proteinases. Bacterial colonization of the gut at this time could also increase the proteinase load coming to the liver. Viral infection in the liver as evidenced by the demonstration of alpha interferon in Kupffer cells and inflammatory cells is particularly common at this age which could cause monocyte elastase production. In early infancy the liver is clearly at its most vulnerable.
TREATMENT OF exlAT DEFICIENCY

Lung disease
Treatment of established emphysema is limited. Cessation of cigarette smoking can slow the rate of decline in lung function and administration of a bronchodilator can bring about a modest improvement in symptoms. Danazol, a compound related to testosterone but without its androgenic properties, can cause discharge of IXIAT from the liver in subjects of normal phenotype, but in type ZZ homozygotes the response is poor and the serum IX IAT concentration is not substantially improved. 56 Single or double lung transplantation has been carried out in many cases of end-stage emphysema including a number with IXIAT deficiency. The single lung procedure has a relatively small morbidity with good survival and is now regarded as the operation of choice in patients over 50 years of age.? Replacement therapy has been made possible by purification of IX IAT from plasma derived from blood donors screened for HIV and hepatitis viruses.P-" The therapeutic agent has been administered intravenously to a number of IXIAT deficient patients with few side-effects. The half-life of the infused protein in vivo is only about 5 days so that it was at first administered weekly, in a dose of 60 rng/kg body weight. 60, 61 Weekly infusion is often inconvenient and it has been shown that monthly infusion in a much larger dose of 250 mg/kg body weight can, for most of this period, raise plasma levels above a theoretical baseline at which lung tissues are presumed to be protected.F A controlled trial of such therapy has never been carried out but in view of the expense and arduous nature of the potential drug regime, it is clearly necessary to demonstrate that the rate of decline in lung function can be significantly slowed; a pilot study has indicated that such a trial can be done.P It is important to obtain the best possible estimate of the total number of type ZZ individuals in any community for planning purposes now that replacement therapy is potentially available. The human IX IAT gene has been transferred to the sheep'" so that IX IAT is produced in the milk; this is fully glycosylated and would thus, when purified, be expected to have a normal half-life in the human. A genetically engineered form of IXIAT, more resistant to oxidative inactivation than the natural protein, has been produced by replacement of the active-site methionine by valine;65 administration of this substance might, however, have serious con seq uences through interference with the normal inflammatory processes.
Recombinant IXIAT can be produced in a yeast but is not glycosylated in this organism; in IX 1A T deficiency 237 this form IXIAT is metabolized much more rapidly and its in vivo half-life after intravenous administration is therefore only a matter of hours, too short to be of practical therapeutic use,66 This and other forms of IX IAT can be administered by aerosol but there is some doubt whether adequate concentrations can be achieved in the lung interstitium by this method.s? Antileucoproteinase can likewise be produced in a yeast and has been administered intravenously in the animal model without undue sideeffects/" The half-life is again very short. A number of synthetic elastase inhibitors of low molecular weight have been synthesized but none has yet been shown to be suitable for human administration. This topic has been reviewed elsewhere. 69,70
Liver disease
The management is that of chronic cholestasis and of cirrhosis. There is no specific treatment for liver disease associated with IX IAT deficiency short of liver transplantation. Liver transplantation should be planned as soon as cirrhosis decompensates, which can occur in early infancy. Successful liver transplantation replaces the abnormal genetic defect and restores the plasma IX IAT level to normal. In the child in whom jaundice has cleared and there has been a period of well-being, the main indications are increasing abdominal distension with loss of muscle bulk, ascites with hypoalbuminaemia, hyponatraemia and recurrence of jaundice. Rarely, severe failure to thrive may prompt transplantation. The onset of haematuria and/or albuminuria due to glomerular lesions is another indication, as are complications of cirrhosis, such as recurrent variceal bleeding not readily prevented by injection therapy. The results are similar to those in other forms of cirrhosis except that hypertension may be more frequent.
The longest follow-up is only 16 years so it is too early to determine whether transplantation will prevent emphysema."
Prospects for gene therapy Replacement of the defective genetic material is an attractive goal and a number of possible methods are being explored. Retroviruses are commonly used for gene transfer to cells in vitro, since genetic material from the virus can be effectively integrated into the genome of the infected cell. A modified virus which has been rendered incapable of replication is used, but because retroviruses insert genetic material into the cell's own genome, they are potentially carcinogenic. The usual practice is for cells to be removed from the proposed recipient, genetically modified in culture and then returned to the recipient. When transplanted into mouse peritoneum, fibroblasts modified in this way continue to produce adAT which can be demonstrated in serum and in the lung. The cdAT gene can be transferred to T'-lymphocytes in the same way. These cells do not have the same capacity for manufacturing protein as fibroblasts but can be transplanted to the lung epithelium. Genetically modified hepatocytes have been infused into the portal vein in an animal model.F the gene is then expressed in the liver and a low but significant level of human ad AT can be recovered in the serum. An alternative approach for the prevention of emphysema is to use an adenovirus, the advantage being that the adenovirus is trophic for respiratory epithelium and is not associated with malignancy. The rx IAT gene is transferred to an adenovirus which is rendered incapable of replication and the treated virus can then be used to infect animal respiratory epithelial cells; the lung tissue can be shown to synthesize and secrete human rxlAT in small quantities." A disadvantage is that epithelial cells are fully differentiated and replicate slowly if at all; the process would therefore have to be continually repeated if used in human subjects. Direct gene therapy targeted to the liver in vivo is another possibility, as it has been used successfully to stimulate albumin production in analbuminaemic rats." The gene was contained in a plasmid targeted to the hepatocyte-specific asialoglycoprotein receptor and carried into the hepatocyte by pinocytosis. In this way the PiMZ state would be created. These techniques clearly hold great interest for the future though it remains to be seen whether any of them will be able to produce full protection against emphysema in the rxlAT-deficient human subject. The topic has been fully reviewed by Crystal."
OTHER DISEASES ASSOCIATED WITH rl1AT VARIANTS
A number of studies have identified a role for z l A'T in the immune system," and there is some evidence for an increased incidence of several diseases involving the immune system amongst patients with z l A'T deficiency. Thus an increased frequency of rheumatoid arthritis amongst MZ heterozygotes has been reported," 
LABORATORY DIAGNOSIS OF «tAT DEFICIENCY
No single assay for rxlAT provides sufficient information in all circumstances, so that the assay or combination of assays chosen will depend on the purpose(s) for which the investigation will be performed. Thus quantitation of serum rxlAT is relatively simple, butparticularly in relation to liver disease---cannot be relied upon to detect PiZZ individuals. This is because rxlAT is an acute phase protein whose secretion from the liver can be markedly influenced by a variety of factors, and also because the pathogenesis of liver disease is only indirectly related to serum concentration of the protein. The availability of an appropriate quality assurance scheme for quantitative assays is an advantage not currently available for the other tests, however, and for the initial investigation of lung disease in adults quantitation may have a role. In general, laboratory diagnosis is now based primarily on phenotyping by isoelectric focusing of'e IAT, but determination of serum concentration of rx IAT can be a useful adjunct to phenotyping, particularly for the identification of null genes. A major advantage of phenotyping is that most variants can be detected in a single assay, though identification of phenotypes requires some experience. Variability in intensity of staining and microheterogeneity can result in erroneous diagnosis, so that phenotyping is best carried out in specialized laboratories. For adult patients, the phenotype should always be obtained by isoelectric focusing, with further DNA-based tests if any doubts remain. Knowledge of the phenotype is important for prognostic purposes and essential for genetic counselling, which almost inevitably arises in discussion with the patient. It can be argued that quantitative analysis is of little use except in rare cases and could for the most part be abandoned. In the infant with cholestasis Pi phenotyping is essential. Note that some PiZZ individuals will have the appearance of PiSZ and require family or DNA studies for full characterization.
DNA analyses are currently used primarily for prenatal diagnosis, and with techniques available at present it is possible to identify only a limited number of mutations in each test. With the exception of very rare mutations. it is generally only the PiZZ genotype which is of interest in liver disease. however. and DNA tests generally give unequivocal results. In the context of genetic counselling. unequivocal detection of the MZ carrier state is desirable. In view of the possible confusion of types MM and MZ by isoelectric focusing methods. DNA based assays should now be available for this purpose.
Quantitation of serum IX I AT Several immunological methods are used for quantitation of serum :xIAT. and quality assurance schemes (e.g. UK NEQAS) are available to monitor the precision and accuracy of results. Widely used methods include automated nephelometry (e.g. using Beckman or Behring equipment). radial immunodiffusion (most frequently using 'Partigen' plates supplied by Behring) or turbidimetry (using discrete analysers). Quantitation of :x I AT has been complicated by the fact that many of the standards used yield values which are markedly at variance with currently accepted 'true' values. Thus. using the standard supplied with Behring radial immunodiffusion plates. the 'normal' serum concentration of :x IAThas been quoted as 1·9 3·5g!L. 'True' values are lower and can be estimated by multiplying values by 0·71. h l Thus several reference ranges are currently in use, and some laboratories prefer to quote serum :x IAT as a percentage of the concentration in a pooled sample of normal serum. With the introduction of a new 'reference preparation for proteins in human serum'. it is to be hoped that this rather confusing situation will soon be simplified."
Phenotyping of IX I AT Electrophoresis
The early studies which identified different forms of :x IAT were performed by starch and cellulose acetate electrophoresis, but isoelectric focusing (IEF) on acrylamide gels under nonreducing conditions is now used virtually universally.!" The pH gradients required for IEF can be generated using carrier ampholytes. Prepared gels (PAGplates. pH 4·0 5'0) supplied by Pharmacia give results which are adequate IX!AT deficiency 239 for phenotyping in most clinical situations. The PhastSystem (Pharmacia) uses prepared minigels in a dedicated system. and allows rapid phenotyping."' Somewhat better resolution can be obtained using the separator ACES (N-(2acetamido)-2-aminoethanesulphonic acid. as described by Weidinger et a/. X2 These conditions allow resolution of up to eight M variants. the pKa of which differ by as little as 0·00 I pH unit. though this degree of resolution is only required for research or forensic purposes, The patterns obtained when :x I AT proteins are separated by isoelectric focusing are shown in Fig. 2 . Although it is possible to identify eight bands. two major bands (4 and 6. which account for 75% of the protein) and three minor bands (2. 7 and X) can usually be distinguished. Most of the complexity is due to variations in carbohydrate attached to the proteins. though live amino acids have been deleted from the proteins in bands 7 and X which have the same carbohydrate structures as bands 4 and 6. Amino acid changes which affect the charge of :x IAT result in a shift of the entire pattern of bands towards the anode (e.g. F) or cathode (e.g. Sand Z). With the reduced concentration of protein associated with the Z mutation (12-18% of normal in homozygotes). it is usually possible to see only the two major bands. In heterozygotes. the two parental genes are codominantly expressed. so that in most cases both alleles are readily identified after electrophoretic separation. An exception is the situation where one allele is null. The pattern observed will then be determined entirely by the one functioning allele and will appear homozygous. The only clue to the presence of a null allele may then be the reduced concentration of protein.
Unfortunately, the pattern of bands obtained with different sera is not the same, even for individuals with the same genotype, and correct interpretation requires some experience. One factor which is known to affect the pattern is penicillamine, which appears to interact with iXIAT via sulphydryl groups.f" More seriously, the extremely variable patterns associated with homozygotes can result in confusion with SZ patterns.P
In the pH range 4·2 to 4,9, the major bands of serum proteins detectable are due to a l A'T, so that non-specific staining with Coomassie Blue is usually adequate for identification of phenotypes. Immunostaining with antiserum to oclAT after transfer to nitocellulose sheets gives results which are slightly easier to interpret, however. Treatment of samples with reducing agents (dithiothreitol or cysteine) to block the active thiol group of e l A'T is recommended unless samples are freshly obtained. We have found that heparin obscures results, so blood collected in EDTA is preferable though analysis can also be carried out on dried blood (Guthrie) spots.
Site-specific antibodies
Monoclonal antibodies which specifically recognize PiZ oclAT86 were used for establishing an ELISA assay. Zegers et al. 88 prepared a monoclonal antibody which could recognize only non-Z iXIAT, as well as a Z-specific antibody which they used for developing an immunoblot assay. These immunoassays should be well suited for screening large numbers of samples to detect the Z protein, though they have not yet found widespread use.
DNA assays
In one of the earliest applications of DNA technology to the direct identification of a point mutation, Kidd et al. s9 hybridized synthetic oligonucleotides to genomic DNA for the identification of the Z mutation. With the advent of the polymerase chain reaction (PCR), DNA analysis has been made considerably easier.
Detection of point mutations is greatly facilitated when the mutation either creates or destroys a site for a restriction enzyme. Unfortunately, the Z mutation does not fall into this category. A simple restriction fragment length polymorphism (RFLP) analysis can be carried out, however, which makes use of a Ann Ctin Biochem 1997: 34 restncuon site for the enzymes MaelII or BstEII. This site is located in exon 3 (the Z mutation occurs in exon 5) but is sufficiently close to the mutation site to be used for linkage studies in families. Although the restriction site is absent in virtually all alleles carrying the Z mutation, it is also absent from about onequarter of normal alleles.f Thus not all families are 'informative', and analysis of a further polymorphic site is often needed. In about one quarter of normal alleles, a deletion of about 2000 bases is found in a closely related gene which is located about 10000 bases downstream from the oclAT gene (the 'PIL' gene). Using a combination of these two polymorphisms, Abbott et al. 89 described prenatal diagnoses for 15 families, 14 of which were informative with one or other combination of polymorphisms.
Various modifications of the PCR have been developed to allow detection of Z and S mutations. Thus Tazelaar et al,90 and Andresen et al'" have introduced base mismatches close to the mutation sites so that restriction sites are created which allow differentiation between Z and M alleles. Similarly, the amplification refractory mutation system (ARMS) makes use of destabilizing mismatches in PCR primers which are complementary to the mutation site. 92 In the latter system, use of one set of primers results in a product only with the mutant allele, while use of another set of primers produces a product only with an allele lacking the mutation (Fig. 3) . We have carried out 17 prenatal diagnoses (S. Chambers and M. Norman, unpublished results) using the polymorphic sites described by Abbott et al. K9 as well as a multiplex ARMS assay for Sand Z mutations. The need for using independent tests whenever possible for prenatal diagnoses is illustrated by the results of our study. With four samples, results were obtained using the ARMS assay when we were unable to obtain results using polymorphic sites (due to inability to amplify DNA with three samples and due to lack of informativeness with one SZ sample). With one chorionic villus sample (CVS) submitted from another hospital, however, different results were obtained with the two types of assay (MZ versus ZZ). This discrepancy was probably a result of maternal (M) contamination which interfered with the ARMS assay. With all other samples, the assays gave identical results. DNA tests such as the ARMS assay should be well suited for use in addition to, or instead of, phenotyping for Functional assays Various functional assays have been developed which are designed to assess inhibition of trypsin diagnosis or screening. We have also found the ARMS test a useful alternative test in prenatal diagnosis. though in this situation some caution is necessary since because of the assay sensitivity slight contamination with maternal DNA may give a misleading result. or elastase acuvuy by serum (e.g. the method described by Lloyd and Travis'"). Functional assays provide useful information. but because they are affected by other inhibitors (such as~2 macroglobulin). their use in diagnosis is limited.
GENETIC IMPLICATIONS AND COUNSELLING
A family bearing the Z gene may come to medical attention either when a type Z homozygote develops respiratory disability due to emphysema. or when a child with liver disease is investigated. Discussion of the genetic implications may then be required. A diagnosis of~-I antitrypsin deficiency should always be based on phenotype analysis and never on quantitative analysis alone. The majority of type Z homozygotes are the children of two MZ heterozygotes. each of whose offspring has a one in four chance of possessing the ZZ phenotype. Full brothers and sisters of these cases should therefore be advised to have their own phenotypes ascertained. but they can rest assured that only a minority of ZZ individuals seem to develop emphysema and that the risk is much reduced by abstinence from smoking. In paediatric practice. a particular problem may arise if a ZZ infant develops severe liver disease. Any subsequent child who is homozygous ZZ has a 70 80% chance of developing liver disease of similar severity." The fetal Pi type can be assessed at or before 10 weeks of pregnancy by chorionic villus sampling and DNA analysis." In families where a previous child has been severely affected by liver disease. the parents will often choose termination of pregnancy if a ZZ fetus is detected.
Type ZZ individuals. especially those with emphysema. are frequently much concerned in case their children should also develop serious disease. In these circumstances. the spouse is very likely to be of the M M phenotype (8()""-90% of population) in which case all children are 'obligatory heterozygotes' and therefore of type MZ. Such parents can be reassured that their children have very little risk of developing emphysema provided that they never take up smoking. The children are. however. 'carriers' of the Z gene. so that marriage with a spouse of the same phenotype can produce a ZZ child in the next generation. It is usually simplest to phenotype the prospective marriage partners when the situation arises and it seems reasonable B.'IEII +: (7) B.'IEII f . (X) B.'IEII ±; and (9) MS Llanes 3 a,,(14) . SS I lanes 5 and fJ). MM Ilane 7 and X). MZ Ilanes 9 and J()). ZZ (lane II and 11). MM t lanc 13 and 14) . SZ (lanes 15 and ts) . to offer the test to any other relatives who wish to have it done.
General testing of cousins or more distant relatives of PiZ homozygotes is not worthwhile as further homozygous PiZ subjects are seldom detected by this means. A number of MZ heterozygotes may be identified, however, who may-incorrectly-be led to believe that they have the severe form of the deficiency with a high risk of emphysema.
Further difficulties, often unjustified, may arise in employment, in obtaining insurance or in family relationships. Clearly no screening should be done unless fully informed counselling facilities are available. Screening of selected populations for a genetic disorder has the theoretical benefit of preventing or ameliorating its clinical effects, but at least one study suggests that screening in the absence of any definitive treatment may create more anxiety than potential benefit. A total of 127 homozygotes PiZ infants were detected out of a total of 200 000 newborns screened in a large Swedish study." About 10% had neonatal cholestasis and on follow up to the age of 12,43 nearly all had recovered though three had died ofliver disease. A cost-benefit analysis'" revealed a number of adverse psycho-social sideeffects on the families and an increase in parental smoking instead of the decrease which one would have expected. Screening of a teenage population (perhaps at the time of BCG vaccination) might encourage any homozygous PiZ individuals detected to stop smoking or never to start. PCR methods could be used to analyse DNA samples obtained by mouthwash or buccal smear which would doubtless be more acceptable in this age group than a blood sample. Again the advantages might not be great in relation to the cost and effort of such a programme.
SUMMARY
(1) Deficiency of IXIAT is one of the most common hereditary diseases affecting Caucasians in Europe. The IX1AT protein is extremely pleomorphic, and around 90 variants due to mutations have been recognized. The prime function of 1X1AT is to inhibit neutrophil elastase, and a proportion of individuals who are deficient in 1X1AT develop emphysema. The most common deficiency variant (Z) is also associated with liver disease. The main site of 1X1AT synthesis is in the liver. Not all deficient individuals are affected by lung or liver disease, Ann Clin Biochem 1997: 34 however, so that other factors (genetic and environmental) are clearly important.
(2) Investigation of IXIAT status is essential in any child or adult presenting with chronic liver disease. The genetic cause cannot be identified clinically or by any other laboratory investigation. The diagnosis carries important prognostic consequences and is important for other family members. Patients with emphysema should have their Pi type determined, especially if they are under the age of 50, have never smoked or there is a suggestive family history. Asymptomatic individuals who are homozygous type Z should be referred to a chest physician for a clinical and radiological assessment together with lung function tests.
(3) Several laboratory tests are available to detect IXI AT deficiency, and the choice of test(s) will depend on circumstances. Quantitation of the serum protein is simple and cheap. Because IXI AT is an acute phase protein, however, quantitation used in isolation may give false negative results which are clearly unacceptable, particularly in association with paediatric liver disease. Phenotyping by isoelectric focusing requires some experience in distinguishing SZ and ZZ phenotypes, and phenotyping should ideally be used in conjunction with quantitation because heterozygous null phenotypes may appear identical to homozygous normal phenotypes.
(4) Prenatal diagnosis is usually performed by DNA analysis of CVS samples obtained at 11-13 weeks. Because of the risk that CVS samples might be contaminated by maternal tissue, assays which are less likely to detect minor contaminants are preferable. At present, use of DNA tests is confined to prenatal diagnosis, but the availability of simple tests and the possibility of unequivocal identification of Sand Z alleles means that these tests are likely to find greater use in the near future.
